Filter
191
Text search:
dolutegravir
Featured
Recommendations
21
New Publications
40
Language
Document type
No document type
77
Guidelines
48
Studies & Reports
35
Manuals
9
Strategic & Response Plan
7
Fact sheets
6
Training Material
4
Situation Updates
2
Infographics
2
Countries / Regions
South Africa
9
Argentina
7
Global
6
Malawi
5
Namibia
4
Latin America and the Carribbean
4
Kenya
3
Africa
3
Uganda
2
Brazil
2
Botswana
2
Myanmar / Burma
2
South–East Asia Region
2
Guinea
1
Nigeria
1
Congo, Democratic Republic of
1
Ethiopia
1
Zimbabwe
1
Philippines
1
India
1
Somalia
1
Nepal
1
Zambia
1
Thailand
1
Rwanda
1
Mozambique
1
Central African Republic
1
Peru
1
Ukraine
1
Colombia
1
Bolivia
1
Lesotho
1
Chile
1
Western Pacific Region
1
Western and Central Europe
1
Venezuela
1
North America
1
Authors & Publishers
Publication Years
Category
Countries
45
Clinical Guidelines
25
Women & Child Health
4
Pharmacy & Technologies
2
Public Health
1
Key Resources
1
Toolboxes
HIV
127
TB
11
Pharmacy
8
AMR
4
COVID-19
3
NTDs
3
Conflict
2
Refugee
2
Mental Health
2
Malaria
1
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep
...
The Department of Health (DOH) has developed a National Integrated Sexual and Reproductive Health and Rights (SRHR) Policy.1 This policy addresses the many cross-cutting issues relating to SRH service provision, drawing together the principles, rights, and guidance for planning and implementation th
...
20 YEARS OF STRATEGIC HIV AND PUBLIC HEALTH DATA . beThe completion of the 6th South African National HIV Prevalence, Incidence and Behaviour Survey (SABSSM) report, coincides with the celebration of 30 years of democracy in South Africa; and marks 20 years of conducting nationally representative ho
...
This brief report summarizes recent information on HIV drug resistance (HIVDR) in the era of integrase-strand transfer inhibitors (INSTI) for HIV prevention and treatment.
Country tables & figures
Developed through broad and inclusive consultation, and aligned with the WHO Global Health Sector Strategies and the Sustainable Development Goals, the framework promotes a people-centred approach and antimicrobial stewardship across 5 key domains: prevention and response, surveillance, research and
...
During ARV drug pressure the HIV-1 RT is able to develop resistance to these drugs by generating mutations
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
recommended
This document provides an overview of the updated World Health Organization recommendations for HIV clinical management, which focus on optimizing antiretroviral therapy, preventing vertical transmission, and enhancing tuberculosis prevention among individuals with HIV. These updates are intended to
...
Policy information sheet
In 2023, 6.7 million [6.1 million–7.5 million] people living with HIV were residing in Asia and the Pacific, making this the world’s largest epidemic after eastern and southern Africa. The region accounts for a quarter of annual new HIV infections globally (23%). People from key populations and
...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
